Home/Filings/4/0000899243-23-018209
4//SEC Filing

CARLSON CAPITAL L P 4

Accession 0000899243-23-018209

CIK 0001733413other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 5:29 PM ET

Size

13.5 KB

Accession

0000899243-23-018209

Insider Transaction Report

Form 4
Period: 2023-08-15
Transactions
  • Sale

    Common Stock, par value $0.001 per share (the "Common Stock"

    2023-08-15$0.44/sh215,000$94,0415,065,000 total(indirect: See footnotes)
  • Sale

    Common Stock

    2023-08-16$0.39/sh1,000$3925,064,000 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock, par value $0.001 per share (the "Common Stock"

    2023-08-15$0.44/sh215,000$94,0415,065,000 total(indirect: See footnotes)
  • Sale

    Common Stock

    2023-08-16$0.39/sh1,000$3925,064,000 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2023-08-16$0.39/sh1,000$3925,064,000 total(indirect: See footnotes)
  • Sale

    Common Stock, par value $0.001 per share (the "Common Stock"

    2023-08-15$0.44/sh215,000$94,0415,065,000 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock, par value $0.001 per share (the "Common Stock"

    2023-08-15$0.44/sh215,000$94,0415,065,000 total(indirect: See footnotes)
  • Sale

    Common Stock

    2023-08-16$0.39/sh1,000$3925,064,000 total(indirect: See footnotes)
Footnotes (4)
  • [F1]The transactions referenced herein provide for various per share prices ranging from $0.405886 to $0.46. The Reporting Persons undertake to provide to the Staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.
  • [F2]The shares of Common Stock to which this relates are held directly by Double Black Diamond Offshore Ltd., a Cayman Islands exempted company (the "Fund").
  • [F3]Carlson Capital, L.P., a Delaware limited partnership ("Carlson Capital") serves as the investment manager to, and has the power to direct the affairs of, the Fund. Asgard Investment Corp. II, a Delaware corporation ("Asgard II") serves as the general partner of, and has the power to direct the affairs of, Carlson Capital. Mr. Clint D. Carlson, a U.S. citizen, serves as the president of, and has the power to direct the affairs of, Asgard II and Carlson Capital. Each of the reporting persons disclaims beneficial ownership of the securities to which this Form 4 relates for the purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of the reporting person's pecuniary interest in the securities.
  • [F4]The transactions referenced herein provide for various per share prices ranging from $0.38 to $0.436. The Reporting Persons undertake to provide to the Staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.

Issuer

TFF Pharmaceuticals, Inc.

CIK 0001733413

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001056973

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:29 PM ET
Size
13.5 KB